As cancer cases rise across India, oncologists stress that early detection and awareness must advance alongside medical ...

BillionToOne is growing rapidly in prenatal and oncology testing. Click here to explore BLLN's financials, market risks, and ...

The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...

Discover key insights from McKesson’s Q2 2026 earnings call, including record growth, raised guidance, and strategic investments.

Episcopal Health Services (EHS) announced the appointment of Dr. Mark Ashamalla, MD, as the hospital's new Chief of Radiation ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Columbia University received a major grant renewal from the National Institutes of Health to fund its comprehensive cancer ...

NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...

The firm is now offering combined ex vivo drug sensitivity and genomic testing to cancer patients outside the clinical trial setting.

A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated ...